肥大細(xì)胞類糜蛋白酶1(CMA1)多克隆抗體(異硫氰酸熒光素標(biāo)記)
FITC-Linked Polyclonal Antibody to Chymase 1, Mast Cell (CMA1)
CYH; CYM; Alpha-chymase; Mast cell protease I
- 編號(hào)LAG515Mu81
- 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
- 來(lái)源抗體標(biāo)記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物熒光素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IF.
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 907 ¥ 2117 ¥ 3024 ¥ 7560 ¥ 30240
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對(duì)CMA1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別CMA1。
用法
免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學(xué):5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPG515Mu01 | 肥大細(xì)胞類糜蛋白酶1(CMA1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAG515Mu01 | 肥大細(xì)胞類糜蛋白酶1(CMA1)多克隆抗體 | WB,IHC |
PAG515Mu02 | 肥大細(xì)胞類糜蛋白酶1(CMA1)多克隆抗體 | WB; IHC; ICC; IP. |
LAG515Mu81 | 肥大細(xì)胞類糜蛋白酶1(CMA1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAG515Mu71 | 肥大細(xì)胞類糜蛋白酶1(CMA1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
SEG515Mu | 肥大細(xì)胞類糜蛋白酶1(CMA1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMG515Mu | 肥大細(xì)胞類糜蛋白酶1(CMA1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Pathobiology | Anti-Angiotensin and Hypoglycemic Treatments Suppress Liver Metastasis of Colon Cancer Cells [Karger: 000330169] |
Clinical and Experimental Metastasis | Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer [PubMed: 22552372] |
Mediators of Inflammation | Mediators of Mast Cells in Bullous Pemphigoid and Dermatitis Herpetiformis [Pubmed:25400334] |
Neurogastroenterology & Motility | Peritoneal mast cell degranulation and gastrointestinal recovery in patients undergoing colorectal surgery [Pubmed:25677271] |
IJC Metab Endocr | The autocrine role of tryptase in pressure overload-induced mast cell activation, chymase release and cardiac fibrosis [PubMed: 26722642] |
Journal of?Neuroinflammation | Oral sensitization to whey proteins induces age-and sex-dependent behavioral abnormality and neuroinflammatory responses in a mouse model of food?… [Pubmed:29685134] |
Revista do Instituto de Medicina Tropical de S?o Paulo | Vasoactive intestinal peptide degradation might influence Interleukin-17 expression in cardiac chagasic patients [Pubmed: 30365640] |
Science Advances | Platelets trigger perivascular mast cell degranulation to cause inflammatory responses and tissue injury [Pubmed: 32206714] |
Immunity Inflammation and Disease | Disruption in the balance between apolipoprotein A‐I and mast cell chymase in chronic hypersensitivity pneumonitis [Pubmed: 33016012] |
Microbiol Spectr | Mast Cell-Derived Proteases Induce Endothelial Permeability and Vascular Damage in Severe Fever with Thrombocytopenia Syndrome [Pubmed:35612327] |